Lupus patients are not getting sick from CCP virus


Sermo Reports Week 3 Results: Globally 17% Point Increase in COVID Treaters Who Have Used Hydroxychloroquine (33%-50%) and Azithromycin (41%-58%)
Percentage of New York Physicians Who Have Used Hydroxychloroquine Nearly Doubled, Italian and French Physicians Jumped 30% Points + Over 2 Weeks

Plasma Still Perceived as Most Effective but Not Widely Used

Perception of Hydroxychloroquine’s Efficacy is Significantly Higher Among Physicians in Europe and China vs US Physicians (50% vs 29%)


(Graphic: Business Wire)


April 15, 2020 11:42 AM Eastern Daylight Time
NEW YORK--(BUSINESS WIRE)--Week three data of the Barometer study from 4016 physicians in 30 countries conducted by Sermo reveals the emergence of treatment patterns and efficacy perceptions. Sermo, the largest global healthcare polling company and social platform for physicians, has published unrestricted access to the results of its Real Time Barometer study on sermo.com. 

Key findings:

In Wave 3 we explored perceptions of physicians who were high vs moderate vs low treaters of COVID patients. The total number of physician respondents for Wave 3 was 4016. Of those, 33% treated COVID patients (n=1337).

The COVID treaters (1337) breakdown was:

  • 42% of COVID treaters have treated between 1-5 patients
  • 20% of COVID treaters have treated between 6 -10 patients
  • 38% of COVID treaters have treated between 11 and more patients
We did not find significant differences between highly active and low active COVID treaters in the below findings.

Usage patterns among COVID treaters (N= 1337)

  • The top three treatments that doctors reported having prescribed were Azithromycin (58%), Hydroxychloroquine (50%), and Bronchodilators (48%); traditional Chinese medicine has been used by 67% of physicians in China.
Week over week increases in usage

  • Percentage of physicians in New York who have used Hydroxychloroquine nearly doubled since Wave 1 week of March 25 (23% to 40% to 43% wave over wave).
  • Italy and France had the highest increase in COVID treaters having prescribed Hydroxychloroquine wave over wave; an increase from 50% to 83% for Italy and an increase from 20% to 50% for France.
  • The number of COVID treaters that report having used Hydroxychloroquine and Azithromycin both increased 17% points since Wave 1 the week of March 25.
    • Hydroxychloroquine Wave 1: 33%, Wave 2: 44%, Wave 3: 50%
    • Azithromycin Wave 1: 41%, Wave 2: 50%, Wave 3: 58%
  • The number of COVID treaters that report having used Bronchodilators increased 12% points (from 36% to 48%) week over week.
  • Usage of anti-HIV drugs (e.g. Lopinavir plus Ritonavir), drugs to treat the flu (e.g. Oseltamivir), and plasma from recovered patients remains steady week over week, while use of non-approved drugs (e.g. Remdesivir) decreased slightly.
Perceived treatment efficacy

  • Physicians who treat COVID patients in Italy, Spain, France, and China have higher perceptions of Hydroxychloroquine’s efficacy vs the US (~50% vs 29%).
  • The top treatments that have been used/seen used and reported as very or extremely effective among COVID treaters (N= 1337) include:
    • 46% plasma from recovered patients (n=363); 40% Hydroxychloroquine (n=875); 38% high dose steroids during a cytokine storm (n=556)
    • No significant differences of perceived efficacy were observed between highly active COVID treaters and users of these drugs (physicians treating 11+ patients) and lower active COVID treaters (1-10 patients)
    • 55% of physicians in China who have used traditional Chinese medicine rated traditional Chinese medicine as effective or extremely effective
Most popular Hydroxychloroquine dosage regimen

  • 75% report using 400mg BID on day one (800mg total), then 400 mg daily for 4-5 days
  • 10% report using 600mg BID on day one (1,200mg total), then 400 mg daily for 4 days
Methodology

Most results are reported for individual countries with a minimum sample size of 250. A sample size of 250 point estimates have a precision of a +/- 6% precision at a 94% confidence level. Where sample sizes are smaller, N sizes are noted. Thirty countries included in the study are the United States, Canada, Argentina, Brazil, Mexico, Germany, Italy, the United Kingdom, France, Spain, Belgium, the Netherlands, Sweden, Turkey, Poland, Russia, Finland, Ireland, Switzerland, Austria, Denmark, Norway, Greece, Taiwan, Japan, South Korea, Australia, China, India, and Hong Kong. No incentive was offered to respondents. Full methodology.

 About Sermo

Sermo is the largest healthcare data collection company and social platform for physicians, reaching 1,3MM HCPs across 150 countries. The platform enables doctors to anonymously talk real-world medicine, review treatment options via our proprietary Drug Ratings platform, collectively solve patient cases, and participate in medical market research. For more information, visit sermo.com.

https://www.businesswire.com/news/home/20200415005517/en/Sermo-Reports-Week-3-Results-Globally-17
 
Stop trolling DNC points.

The number of people that have been saved by the use of this medicine is impossible to count.

https://thehill.com/opinion/healthc...ine-could-cure-trump-derangement-syndrome?amp

"The number of people who have been saved by the use of this medicine is impossible to count" because the proven number is ZERO.

It would be great to have studies prove hydroxychloroquine based therapy is an effective treatment for COVID-19, but the initial results of proper studies have not been promising.

I support doctors using it experimentally and I support studies looking at its effectiveness (and long as all the money for studies of other medicines are not robbed).

But hydroxychloroquine or any other medication should not be hyped by politicians and media pundits as a proven cure for COVID-19. Let the medical community handle it properly.
 
"The number of people who have been saved by the use of this medicine is impossible to count" because the proven number is ZERO.

It would be great to have studies prove hydroxychloroquine based therapy is an effective treatment for COVID-19, but the initial results of proper studies have not been promising.

I support doctors using it experimentally and I support studies looking at its effectiveness (and long as all the money for studies of other medicines are not robbed).

But hydroxychloroquine or any other medication should not be hyped by politicians and media pundits as a proven cure for COVID-19. Let the medical community handle it properly.
More TDS. There are plenty of people who have been about to die that were saved after taking this drug. Does it work for everyone, most likely not. Does it work better with an antibiotic, seems to be. In the meantime while you wait for your studies many people have been saved.

I am just throwing this to show what TDS can do to a brain.

 
More TDS. There are plenty of people who have been about to die that were saved after taking this drug. Does it work for everyone, most likely not. Does it work better with an antibiotic, seems to be. In the meantime while you wait for your studies many people have been saved.

Actually among the severely ill cohort is where hydroxychloroquine based therapy has been proven to have no benefit. In New York, 80% of the COVID-19 patients who are intubated die. The rate is the exact same for those where hydroxychloroquine based therapy was used and for those where it was not. The death rates among the severely ill intubated patients in Europe and Asia show a similar mortality rate - and hydroxychloroquine based therapy does not change the rate. Your statement "here are plenty of people who have been about to die that were saved after taking this drug" is completely false and the medical evidence backs it as not being correct.

The only question now is if hydroxychloroquine based therapy provides improvement in the results for mildly ill hospitalized COVID-19 patients.
 
https://www.sermo.com/ is looking as a very legit non-political organization. gwb-trading obviously knows better than a cohort of doctors. Some people are truly ridiculous.

The number of COVID treaters that report having used Hydroxychloroquine and Azithromycin both increased 17% points since Wave 1 the week of March 25.
  • Hydroxychloroquine Wave 1: 33%, Wave 2: 44%, Wave 3: 50%
  • Azithromycin Wave 1: 41%, Wave 2: 50%, Wave 3: 58%
Yep, according to gwb-trading, all these doctors prescribing Hydroxychloroquine and Azithromycin are doing it out of wack.
 
Yeh. I dunno.

I am just saying, as I have said in previous posts, that the advocates (I am an observer of all approaches, and don't have a dog in the fight other than to keep this dog and others alive) of the hydroxy/ zpac regimen state that it is a three-legged stool where you need all three elements. The hydroxy to move the zinc ion into the cell, and the azithro - which is both an anti-viral and anti-bacterial- to work against the virus and the pneumonia that tends to rear up as the immune system is weakened by the virus.

I just want to increase the speed, precision, and efficiency by which the four or five approaches (remsdesvir, hyrdroxychloriquine, convalescent antibody, etc, etc) are examined and either advanced or dismissed. It doesnt help that those looking at the hydroxy regimen keep mixing and matching the elements included in the methodology.

Right now, if someone put a gun to my head and said I could choose any treatment method that I wanted if I developed covid I would probably say that I would want resdemsivir at the onset, and if I were still struggling in a week, then I would want to add in antibody transfusions.

Might change my mind next week. I am just following this in real time. I will continue to follow and root for the hydroxy regimen along with the others until I see a study that includes all three of the elements that the advocates claim are effective. When i see that, then I will form an opinion from there.

In regard to Trump, I cheer for his advocacy and support for getting approaches examined and available to the public without being blocked by bureaucracy. Beyond that though I am not cheering for a specific drug. Just find out what works and send me some of dat. :cool:
For your review before you jump on the Remsdivir band wagon.

https://www.marketwatch.com/amp/story/guid/F857E1C4-A254-47D4-8B87-04955D4FC31A
 
Actually among the severely ill cohort is where hydroxychloroquine based therapy has been proven to have no benefit. In New York, 80% of the COVID-19 patients who are intubated die. The rate is the exact same for those where hydroxychloroquine based therapy was used and for those where it was not. The death rates among the severely ill intubated patients in Europe and Asia show a similar mortality rate - and hydroxychloroquine based therapy does not change the rate. Your statement "here are plenty of people who have been about to die that were saved after taking this drug" is completely false and the medical evidence backs it as not being correct.

The only question now is if hydroxychloroquine based therapy provides improvement in the results for mildly ill hospitalized COVID-19 patients.
My assertion comes from the actual patients who have used that phrase to recount their ordeal.

If Hydroxychoroquine has kept thousands of people from having to be taken to the ICU and be intubated in the first place, then yes, we can safely say Hydroxychoroquine has saved many lives.
 
For your review before you jump on the Remsdivir band wagon.

https://www.marketwatch.com/amp/story/guid/F857E1C4-A254-47D4-8B87-04955D4FC31A

Yes ..... Remdesivir has faded as being effective, this can also be seen in recent Sermo summaries. It only worked (possibly) when used jointly with Interferon. It seems likely that Remdesivir is not a "cure" for COVID-19.

The medical community should keep driving to determine the best treatment for COVID-19 and continue with relevant studies. The medical community will determine the most effective treatment quickly if they are left to do their scientific work without interference from politicians and media pundits.
 
Last edited:
https://www.sermo.com/ is looking as a very legit non-political organization. gwb-trading obviously knows better than a cohort of doctors. Some people are truly ridiculous.

The number of COVID treaters that report having used Hydroxychloroquine and Azithromycin both increased 17% points since Wave 1 the week of March 25.
  • Hydroxychloroquine Wave 1: 33%, Wave 2: 44%, Wave 3: 50%
  • Azithromycin Wave 1: 41%, Wave 2: 50%, Wave 3: 58%
Yep, according to gwb-trading, all these doctors prescribing Hydroxychloroquine and Azithromycin are doing it out of wack.

The doctors prescribing hydroxychloroquine and azithromycin are doing it as an experimental treatment for COVID-19. They are studying the results of this treatment in many trials. The medical community does not believe hydroxychloroquine and azithromycin is a proven cure; nor do they promote it as such. Currently the evidence is that hydroxychloroquine and azithromycin does not provide any benefit for severely ill COVId-19 patients (as outlined in multiple studies that have been posted). The only question now is if hydroxychloroquine and azithromycin provide any benefit for mild/moderately ill hospitalized COVID-19 patients.
 
Back
Top